Clinical Trial Update: Safety of TG100-115 for Heart Attack Treated With Angioplasty [Phase 1, Phase 2]

View source ↗

Summary

This document reports on the safety findings from Phase 1/2 trials of the investigational compound TG100-115 in patients with myocardial infarction treated with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• TG100-115

Snippet

Sponsor: TargeGen | Conditions: Myocardial Infarction | Phase 1, Phase 2 | Status: COMPLETED